1-20 of 27
Authors: Yuko Kaneko
Sort by
Journal Article
Trans-omics landscape of systemic vasculitis identified matrix metalloproteinase 12 as a novel signature molecule
Kotaro Matsumoto and others
Rheumatology, keaf175, https://doi.org/10.1093/rheumatology/keaf175
Published: 26 March 2025
Journal Article
Five-year follow-up of patients with difficult-to-treat rheumatoid arthritis
Satoshi Takanashi and others
Rheumatology, Volume 64, Issue 5, May 2025, Pages 2487–2495, https://doi.org/10.1093/rheumatology/keae325
Published: 08 June 2024
Journal Article
Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis
Hiroto Yoshida and others
Rheumatology, Volume 63, Issue 9, September 2024, Pages 2515–2524, https://doi.org/10.1093/rheumatology/keae196
Published: 26 March 2024
Journal Article
Tocilizumab discontinuation after remission achievement in patients with adult-onset Still’s disease
Hiroya Tamai and others
Rheumatology, Volume 64, Issue 3, March 2025, Pages 1437–1442, https://doi.org/10.1093/rheumatology/keae179
Published: 20 March 2024
Journal Article
The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trials
Kaoru Takase-Minegishi and others
Rheumatology, Volume 64, Issue 2, February 2025, Pages 548–560, https://doi.org/10.1093/rheumatology/keae113
Published: 16 February 2024
Journal Article
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study
Mrinalini Dey and others
Rheumatology, Volume 62, Issue 5, May 2023, Pages e147–e152, https://doi.org/10.1093/rheumatology/keac603
Published: 25 October 2022
Journal Article
Disease-specific expansion of CD29+IL-17RA+ T effector cells possessing multiple signalling pathways in spondyloarthritis
Mitsuhiro Akiyama and others
Rheumatology, Volume 62, Issue 3, March 2023, Pages 1296–1305, https://doi.org/10.1093/rheumatology/keac391
Published: 07 July 2022
Journal Article
Branched chain amino acids in the treatment of polymyositis and dermatomyositis: a phase II/III, multi-centre, randomized controlled trial
Naoki Kimura and others
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4445–4454, https://doi.org/10.1093/rheumatology/keac101
Published: 18 February 2022
Journal Article
Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study
Yoshiya Tanaka and others
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4273–4285, https://doi.org/10.1093/rheumatology/keac075
Published: 08 February 2022
Journal Article
Dermatomyositis-like rash and inflammatory myopathy after mRNA-1273 vaccination
Yasushi Kondo and others
Rheumatology, Volume 61, Issue 7, July 2022, Pages e171–e173, https://doi.org/10.1093/rheumatology/keac038
Published: 20 January 2022
Journal Article
Lupus low disease activity state within 12 months is associated with favourable outcomes in severely active systemic lupus erythematosus
Jun Kikuchi and others
Rheumatology, Volume 61, Issue 9, September 2022, Pages 3777–3791, https://doi.org/10.1093/rheumatology/keac002
Published: 07 January 2022
Journal Article
Comment on: Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease
Mitsuhiro Akiyama and Yuko Kaneko
Rheumatology, Volume 60, Issue 11, November 2021, Pages e412–e413, https://doi.org/10.1093/rheumatology/keab687
Published: 10 September 2021
Journal Article
Immunoglobulin G4–related disease and idiopathic multicentric Castleman’s disease: confusable immune-mediated disorders
Takanori Sasaki and others
Rheumatology, Volume 61, Issue 2, February 2022, Pages 490–501, https://doi.org/10.1093/rheumatology/keab634
Published: 07 August 2021
Journal Article
Characteristics of patients with difficult-to-treat rheumatoid arthritis in clinical practice
Satoshi Takanashi and others
Rheumatology, Volume 60, Issue 11, November 2021, Pages 5247–5256, https://doi.org/10.1093/rheumatology/keab209
Published: 03 March 2021
Journal Article
Comment on: HHV-8-negative multicentric Castleman disease patients with serological, histopathological and imaging features of IgG4-related disease
Mitsuhiro Akiyama and others
Rheumatology, Volume 60, Issue 2, February 2021, Pages e73–e75, https://doi.org/10.1093/rheumatology/keaa753
Published: 30 November 2020
Journal Article
Lymphadenopathy in IgG4-related disease: a phenotype of severe activity and poor prognosis, with eotaxin-3 as a new biomarker
Satoshi Takanashi and others
Rheumatology, Volume 60, Issue 2, February 2021, Pages 967–975, https://doi.org/10.1093/rheumatology/keaa648
Published: 07 November 2020
Journal Article
Biomarkers for disease flare in patients with adult-onset Still’s disease undergoing treatment with tocilizumab
Get access
Hiroki Yamada and others
Rheumatology, Volume 59, Issue 2, February 2020, Pages 440–442, https://doi.org/10.1093/rheumatology/kez392
Published: 05 September 2019
Journal Article
Clinical characteristics of cancer-associated myositis complicated by interstitial lung disease: a large-scale multicentre cohort study
Get access
Yuko Kaneko and others
Rheumatology, Volume 59, Issue 1, January 2020, Pages 112–119, https://doi.org/10.1093/rheumatology/kez238
Published: 25 June 2019
Journal Article
017. SUBTYPES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS ACCORDING TO RHEUMATOID FACTOR
Jun Inamo and others
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez057.016, https://doi.org/10.1093/rheumatology/kez057.016
Published: 29 March 2019
Journal Article
Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease
Get access
Satoshi Takanashi and others
Rheumatology, Volume 58, Issue 6, June 2019, Pages 1034–1039, https://doi.org/10.1093/rheumatology/key420
Published: 08 January 2019
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals